Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuxing Zhang

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Bioconjugate Chemistry|September 1, 2018
Caspase-3 Substrates for Noninvasive Pharmacodynamic Imaging of Apoptosis by PET/CTBrian J Engel, Seth T Gammon, Rajan Chaudhari, et al.
Nature Communications|September 27, 2019
Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signallingNan Li, Yifan Wang, Shinya Neri, et al.
Molecular Cancer Therapeutics|September 16, 2008
Discovery of a novel class of AKT pleckstrin homology domain inhibitorsDaruka Mahadevan, Garth Powis, Eugene A Mash, et al.
JCO Precision Oncology|February 17, 2022
Germline and Somatic Smoothened Mutations in Non-Small-Cell Lung Cancer Are Potentially Responsive to Hedgehog Inhibitor VismodegibAnne S Tsao, Ignacio Wistuba, Dianren Xia, et al.
Molecular Cancer Therapeutics|March 4, 2010
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitorEmmanuelle J Meuillet, Song Zuohe, Robert Lemos, et al.
Cancer Research|October 17, 2019
Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and TumorsMartin Indarte, Roisin Puentes, Marco Maruggi, et al.
Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.
Nature Cell Biology|January 24, 2017
A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasisChunlai Li, Shouyu Wang, Zhen Xing, et al.
Journal of the American Chemical Society|May 14, 2021
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor ActivityPaola Amero, Ganesh L R Lokesh, Rajan R Chaudhari, et al.
Hepatology (Baltimore, Md.)|December 2, 2025
Targeting mTORC2-Dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET-activated and β-catenin-mutated hepatocellular carcinomaXue Wang, Yi Zhou, Shu Zhang, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Bioconjugate Chemistry|September 1, 2018
Caspase-3 Substrates for Noninvasive Pharmacodynamic Imaging of Apoptosis by PET/CTBrian J Engel, Seth T Gammon, Rajan Chaudhari, et al.
Nature Communications|September 27, 2019
Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signallingNan Li, Yifan Wang, Shinya Neri, et al.
Molecular Cancer Therapeutics|September 16, 2008
Discovery of a novel class of AKT pleckstrin homology domain inhibitorsDaruka Mahadevan, Garth Powis, Eugene A Mash, et al.
JCO Precision Oncology|February 17, 2022
Germline and Somatic Smoothened Mutations in Non-Small-Cell Lung Cancer Are Potentially Responsive to Hedgehog Inhibitor VismodegibAnne S Tsao, Ignacio Wistuba, Dianren Xia, et al.
Molecular Cancer Therapeutics|March 4, 2010
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitorEmmanuelle J Meuillet, Song Zuohe, Robert Lemos, et al.
Cancer Research|October 17, 2019
Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and TumorsMartin Indarte, Roisin Puentes, Marco Maruggi, et al.
Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.
Nature Cell Biology|January 24, 2017
A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasisChunlai Li, Shouyu Wang, Zhen Xing, et al.
Journal of the American Chemical Society|May 14, 2021
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor ActivityPaola Amero, Ganesh L R Lokesh, Rajan R Chaudhari, et al.
Hepatology (Baltimore, Md.)|December 2, 2025
Targeting mTORC2-Dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET-activated and β-catenin-mutated hepatocellular carcinomaXue Wang, Yi Zhou, Shu Zhang, et al.
Pageof 9